On Friday, major U.S. stock indices recorded robust gains, with the Dow Jones Industrial Average surging more than 700 points as investors responded positively to a wave of encouraging corporate earnings and strategic moves across multiple sectors.
At the forefront was Strategy Inc. (NASDAQ:MSTR), which witnessed a sharp increase in its share price following the release of its fourth-quarter financial results that surpassed market expectations. The company reported revenues of $122.99 million for the quarter, exceeding analyst consensus estimates of $118.48 million. Additionally, adjusted earnings per share came in at $16.37, significantly outperforming forecasts which projected earnings of $10.96 per share. Strategy Inc. operates as a Bitcoin treasury company, and these strong financials helped drive its stock price up by 14.1% to $122.56 by the close of trading.
Alongside Strategy Inc., several other notable stocks experienced considerable gains. SunOpta Inc. (NASDAQ:STKL) jumped 32.4% to end at $6.40 after its announcement that Refresco plans to acquire the company at $6.50 per share in cash, signaling a substantial premium and strategic consolidation in the beverage sector.
Pulse Biosciences Inc. (NASDAQ:PLSE) saw its shares rise 27.9% to $17.51 after presenting late-breaking data from the nPulse™ Cardiac Catheter System’s first-in-human feasibility study at a key cardiac symposium. This demonstration of clinical advancement contributed to market optimism around the company’s innovation pipeline.
Other technology-related companies also posted strong performances. BTQ Technologies Corp (NASDAQ:BTQ) climbed 21.7% to $2.80, while Applied Digital Corp (NASDAQ:APLD) surged 17.9% to $32.83. Bitfarms Ltd (NASDAQ:BITF) gained 17.3%, closing at $2.00; the company’s board approved a plan to redomicile from Canada to the United States by April 1, 2026, and rebrand as Keel Infrastructure, signaling a strategic repositioning in the digital asset mining sector.
Pharmaceutical and healthcare stocks showed significant movement as well. Roivant Sciences Ltd (NASDAQ:ROIV) advanced 17.2% to $24.78 following quarterly sales results that surpassed expectations. Proto Labs Inc. (NYSE:PRLB) increased 16.8% to $61.55 after releasing better-than-anticipated earnings for the quarter.
BILL Holdings Inc. (NYSE:BILL) experienced a 16.4% rise to $41.57 after reporting stronger-than-expected second-quarter results and elevating its fiscal year 2026 guidance beyond analyst estimates. Lumen Technologies Inc. (NYSE:LUMN) climbed 15.7% to $7.21 while Mitek Systems Inc. (NASDAQ:MITK) rose 15.3% to $11.32, both benefiting from optimistic quarterly earnings reports.
Other companies reporting positive financials that contributed to their stock price gains included Envista Holdings Corp (NYSE:NVST), which increased 14% to $28.21 after exceeding quarterly estimates and issuing fiscal year 2026 adjusted earnings per share guidance surpassing analyst projections. Galaxy Digital Inc. (NASDAQ:GLXY) rose 12.5% to $18.94 after unveiling a $200 million share repurchase program.
Financial technology firms also rallied. Dave Inc. (NASDAQ:DAVE) added 12.4% to $175.30 following preliminary fourth-quarter financial data, and Robinhood Markets Inc. (NASDAQ:HOOD) jumped 10.8% to $80.55. The movement in cryptocurrency-exposed equities coincided with an approximate 8% rebound in Bitcoin prices, helping reverse losses experienced during the preceding session.
Consumer staples and healthcare providers posted appreciable gains as well: Post Holdings Inc. (NYSE:POST) increased 10.2% to $115.01 after delivering strong quarterly results. Novo Nordisk A/S (NYSE:NVO) rose 7.4% to $46.56, while Arm Holdings PLC – ADR (NASDAQ:ARM) added 7.4%, closing at $119.06 following the release of third-quarter results.
Additional notable advances were recorded by Teradyne Inc. (NASDAQ:TER), which rose 7.1% to $290.43, and Estee Lauder Companies Inc. (NYSE:EL), up 7% to $103.40. The latter's improvement was supported by a Citigroup analyst upgrade from Neutral to Buy with a maintained price target of $120.
The overall market momentum on Friday reflected a combination of solid earnings beats, strategic corporate maneuvers such as mergers and redomiciliations, and sector-specific developments particularly in financial technology and biotechnology domains. These factors collectively fostered investor confidence, spurring a wide-reaching rally across diverse industries.